145 related articles for article (PubMed ID: 16257462)
1. Inflammatory markers are not associated with outcomes following elective external cardioversion.
Cosgrave J; Foley JB; Bahadur K; Bennett K; Crean P; Walsh MJ
Int J Cardiol; 2006 Jun; 110(3):373-7. PubMed ID: 16257462
[TBL] [Abstract][Full Text] [Related]
2. Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm.
Beck-da-Silva L; de Bold A; Fraser M; Williams K; Haddad H
Can J Cardiol; 2004 Oct; 20(12):1245-8. PubMed ID: 15494777
[TBL] [Abstract][Full Text] [Related]
3. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M
Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472
[TBL] [Abstract][Full Text] [Related]
4. Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation.
Tveit A; Seljeflot I; Grundvold I; Abdelnoor M; Smith P; Arnesen H
Am J Cardiol; 2007 Jun; 99(11):1544-8. PubMed ID: 17531578
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of inflammatory and oxidative markers following the successful cardioversion of persistent lone atrial fibrillation.
Leftheriotis DI; Fountoulaki KT; Flevari PG; Parissis JT; Panou FK; Andreadou IT; Venetsanou KS; Iliodromitis EK; Kremastinos DT
Int J Cardiol; 2009 Jul; 135(3):361-9. PubMed ID: 18640731
[TBL] [Abstract][Full Text] [Related]
6. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion.
Ari H; Binici S; Ari S; Akkaya M; Koca V; Bozat T; Gürdoğan M
Turk Kardiyol Dern Ars; 2008 Oct; 36(7):456-60. PubMed ID: 19155659
[TBL] [Abstract][Full Text] [Related]
7. Myocardial injury, neurohormonal activation and inflammation after internal atrial defibrillation.
Boodhoo LE; Mitchell AR; O'Connor J; Sulke N
Int J Cardiol; 2005 Aug; 103(1):67-72. PubMed ID: 16061126
[TBL] [Abstract][Full Text] [Related]
8. Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation.
Climent V; Marín F; Mainar L; Roldán V; García A; Martínez JG; Lip GY
Int J Cardiol; 2009 Feb; 132(2):227-32. PubMed ID: 18234374
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
Lombardi F; Tundo F; Belletti S; Mantero A; Melzi D'eril GV
J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):581-8. PubMed ID: 18475126
[TBL] [Abstract][Full Text] [Related]
10. The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction.
Freestone B; Chong AY; Blann AD; Lip GY
Thromb Res; 2006; 118(4):479-85. PubMed ID: 16318868
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion].
Zarauza J; Rodríguez Lera MJ; Fariñas Alvarez C; Hernando JP; Ceballos B; Gutiérrez B; Pérez J; Cuesta JM
Rev Esp Cardiol; 2006 Feb; 59(2):125-9. PubMed ID: 16540033
[TBL] [Abstract][Full Text] [Related]
12. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion.
Henningsen KM; Therkelsen SK; Bruunsgaard H; Krabbe KS; Pedersen BK; Svendsen JH
Scand J Clin Lab Invest; 2009; 69(3):425-32. PubMed ID: 19204850
[TBL] [Abstract][Full Text] [Related]
14. [Predictive factors of maintenance of sinus rhythm after direct current (DC) cardioversion of atrial fibrillation/atrial flutter].
Larsen MT; Lyngborg K; Pedersen F; Corell P
Ugeskr Laeger; 2005 Sep; 167(36):3408-12. PubMed ID: 16159494
[TBL] [Abstract][Full Text] [Related]
15. Hypertension and paroxysmal atrial fibrillation: a novel predictive role of high sensitivity C-reactive protein in cardioversion and long-term recurrence.
Rizos I; Rigopoulos AG; Kalogeropoulos AS; Tsiodras S; Dragomanovits S; Sakadakis EA; Faviou E; Kremastinos DT
J Hum Hypertens; 2010 Jul; 24(7):447-57. PubMed ID: 20072146
[TBL] [Abstract][Full Text] [Related]
16. Detection of myocardial injury after internal cardioversion for atrial fibrillation.
Gorenek B; Kudaiberdieva G; Goktekin O; Cavusoglu Y; Birdane A; Ata N; Unalir A; Timuralp B
Can J Cardiol; 2004 Feb; 20(2):165-8. PubMed ID: 15010739
[TBL] [Abstract][Full Text] [Related]
17. Self-limited bursts of atrial fibrillation following successful cardioversion.
Nergårdh AK; Rosenqvist M; Frick M
Int J Cardiol; 2007 Jun; 119(1):95-100. PubMed ID: 17064786
[TBL] [Abstract][Full Text] [Related]
18. Time course for recovery of atrial mechanical and endocrine function post DC cardioversion for persistent atrial fibrillation.
Thomas MD; Kalra PR; Jones A; Struthers AD; More RS
Int J Cardiol; 2005 Jul; 102(3):487-91. PubMed ID: 16004895
[TBL] [Abstract][Full Text] [Related]
19. Comparison of anticoagulant and anti-inflammatory responses using enoxaparin versus unfractionated heparin for transesophageal echocardiography-guided cardioversion of atrial fibrillation.
Hoppensteadt D; Fareed J; Klein AL; Jasper SE; Apperson-Hansen C; Lieber EA; Katz WE; Malouf JF; Stoddard MF; Pape LA;
Am J Cardiol; 2008 Oct; 102(7):842-6. PubMed ID: 18805108
[TBL] [Abstract][Full Text] [Related]
20. Activation of generalised inflammatory reaction following electrical cardioversion.
Gajek J; Zyśko D; Mysiak A; Mazurek W
Kardiol Pol; 2004 Sep; 61(9):225-31. PubMed ID: 15531934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
